Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Elevance Health (ELV) Q4 CY2024 Highlights: Revenue: $45.44 billion vs analyst estimates of $45.34 billion (6.6% year-on-year growth, in line) Adjusted EPS: $3.84 vs analyst expectations of $3.85 ...

Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was ...

Bone broth, a nutrient-rich liquid made from simmering animal bones in water, is one of those health trends that just keeps going strong. On social media, many swear by drinking the thick ...

Analysts' ratings for Elevance Health (NYSE:ELV) over the last quarter vary from bullish to bearish, as provided by 6 analysts. Summarizing their recent assessments, the table below illustrates ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price target of $478.00. The company’s shares closed ...

In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Elevance Health (ELV – Research Report), with a price target of $480.00. The company’s shares ...

Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice ...

In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV) stands against the other large-cap value stocks. The market outlook is as uncertain as it gets. On January 18 ...

But rules insurers such as Blue Cross Blue Shield of Michigan, UnitedHealthcare and Elevance Health have recently announced may be a new battleground in the age-old fight between the two camps.